Episodes

Former SEC trial counsel Nick Morgan on how the new SPAC rules affect litigation risk, and why long statutes of limitation mean today's deals could face future scrutiny.

Odyssey Trust's Caitlyn Van Valin on how SPACs helped break one incumbent's hold on the transfer agent market and opened the door for new providers.

Adeel Rouf on why closed IPO windows are sending mid-market companies back to SPACs, and why a wave of 70 to 100 SPACs could suit the 2025-2026 market.

Lockton's Machua Millett on the D&O risk outlook for SPACs and de-SPACs, why this cycle has more experienced sponsors, and why litigation looks less volatile.

Lockton's Machua Millett on how underwriters price D&O risk for SPACs and de-SPAC targets, from sponsor track record to how volatile the target's sector is.

Chaz Churchwell explains why D&O pricing has fallen nearly 60% since the 2021 peak, as the number of carriers writing public D&O doubled and competition drove prices down.

James Campanella on how PIPEs have changed since the 2020 boom, why they now take time, trust, and careful structuring, and the terms that derailed recent deals.

Paul Hastings partner Nick Morgan reflects on representing SPAC clients through SEC investigations during the active 2021-2024 enforcement period.

Odyssey Trust's Caitlyn Van Valin on how real-time reporting portals with 150+ customizable reports give SPAC sponsors, CFOs, and boards instant visibility.

Adeel Rouf on why strong companies from Europe and Asia still pick Nasdaq and the NYSE, drawing on Voyager's SPAC deal with a Swiss biotech firm.

RLH Capital CIO Louis Camhi on his path from Credit Suisse M&A through Three Corner Global and Citadel, and why he launched a SPAC-focused fund in October 2021.

Lockton's Machua Millett on why SPAC boards need a broker who acts as a risk advisor, from educating directors to designing coverage and advocating during claims.

James Campanella on why de-SPAC sponsors must attract long-term fundamental investors, and how institutional anchors helped some of his deals close with minimal redemptions.

Nick Morgan critiques the SEC's regulation by enforcement in the SPAC space, citing the 2021 Momentus Stable Road case and Commissioner Hester Peirce's concerns.

Brookline's Patrick Sturgeon on what separates strong SPAC sponsors from passive ones: industry knowledge, operating experience, and networks that help companies grow.

Adeel Rouf on the real risk-reward tradeoff of being a serial SPAC sponsor, and why sponsors must build executable deal flow well before the IPO.

Louis Camhi on what could spark a SPAC comeback: rising IPO activity, private equity firms seeking liquidity, and success stories like Circle.

Louis Camhi on the convergence of SPACs and crypto, from Cantor's CEP deal to why investors now want operating crypto businesses with real cash flow.

Chaz Churchwell on why D&O policy wording matters, how a single missing phrase like reverse merger has led to denied SPAC claims, and how to fix gaps without raising costs.

James Campanella on what makes an ideal SPAC target: public-ready management first, then strategic fit, synergies, and consolidation plays only a SPAC can unlock.

Nick Morgan argues the SEC should set SPAC policy through Administrative Procedure Act rulemaking, with public comment, rather than one-off enforcement actions.

Odyssey Trust's Caitlyn Van Valin, working on half of all active SPACs, on the S-1 backlog and why she expects a very busy fall for SPAC IPOs.

Brookline's Patrick Sturgeon advises private company CEOs to vet the sponsor team and be honest about readiness, from audited financials to ongoing disclosure costs.

Chaz Churchwell on how his firm serves small and mid-cap public companies that big agencies overlook, and why attorney-led policy wording prevents costly exclusions.